当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
RNA-editing drugs advance into clinical trials
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2024-04-18 , DOI: 10.1038/d41573-024-00070-y
Asher Mullard

ADAR-based editors that can change the mRNA code offer new opportunities in both rare genetic diseases and common complex ones.

中文翻译:

RNA编辑药物进入临床试验

基于 ADAR 的编辑器可以改变 mRNA 代码,为罕见遗传疾病和常见复杂疾病提供了新的机会。
更新日期:2024-04-18
down
wechat
bug